PhD, MD, PharmD, or equivalent in Neuroscience, Biomedical Imaging, Radiology, or related field.
6+ years of industry experience in translational medicine, imaging sciences, or clinical development.
Deep expertise in clinical and translational neuroimaging, particularly MRI and PET methodologies.
Direct experience managing imaging protocols in clinical trials, including endpoints and harmonization.
Experience with imaging endpoints for early-stage clinical development in CNS, ophthalmic, and inflammatory diseases.
Responsibilities
Develop translational strategies to support clinical development and regulatory pathways.
Lead the implementation of imaging strategies for clinical proof-of-mechanism and patient stratification.
Serve as the neuroimaging lead on cross-functional program teams.
Collaborate with Research to discover and characterize novel imaging biomarkers.
Develop and validate imaging methods for clinical use.
Implement clinical biomarkers to drive decision-making throughout drug development.
Lead imaging governance initiatives to demonstrate disease-modifying effects.
Benefits
Opportunity to work with cutting-edge cellular therapies.
Highly visible role with internal and external stakeholders.
Collaboration with a cross-functional team of experts.
Location in Cambridge, Massachusetts, a hub for biotech innovation.
Support for business development efforts, enhancing career growth opportunities.
Full Job Description
Description of Position:
It continues to be an exciting time for BlueRock Therapeutics as the company advances cutting edge cellular therapies to positively impact patients' lives across multiple disease areas.
The Director of Imaging and Biomarkers, Translational Medicine, will be expected to take on a highly visible role with internal and external stakeholders through the management of the imaging protocols and biomarkers leveraged in BlueRock's clinical development programs. The Director of Imaging and Biomarkers will leverage their expertise in CNS, ophthalmic and inflammation imaging to advance the company's development pipeline by working closely with program leads and other subject matter experts. The position will be based in Cambridge, Massachusetts.
Responsibilities:
As a critical member of the Translational Medicine team, the Director of Translational Medicine (Imaging) will leverage their expertise in CNS to:
Develop translational strategies designed to support clinical development plans, the regulatory path, and product commercialization.
Lead the development and implementation of translational imaging strategies in support of clinical proof-of-mechanism, patient stratification, dose selection.
Serve as the neuroimaging lead on cross-functional program teams.
Partner with Research to discover and characterize novel imaging biomarkers in preclinical studies.
Develop imaging methods and analytically validate imaging tools for clinical use.
Implement clinical biomarkers and ensure biomarker-driven decision-making across all phases of drug development.
Lead cross-functional imaging governance (e.g., Imaging Steering Committee) advancing the use of imaging biomarkers to enable demonstration of disease-modifying effects.
Deliver subject matter expertise with respect to clinically advanced techniques in MRI, PET, SPECT, HRCT and other modalities as needed.
Oversee CRO vendor/partners ensuring that they optimally execute clinical and preclinical imaging projects in the US, Canada, and other regions of interest.
Provide support for the Business Development organizations as needed on diligence efforts.
Minimum Requirements:
PhD, MD, PharmD, or equivalent degree in Neuroscience, Biomedical Imaging, Radiology, or related discipline.
6+ years of industry experience in translational medicine, imaging sciences, or clinical development
Deep expertise in clinical and translational neuroimaging, including MRI and PET methodologies
Must have direct experience managing imaging protocols in the conduct of clinical trials (endpoints, inter-site harmonization, imaging core lab oversight, etc.).
Specific experience with imaging endpoints for early-stage clinical development in CNS, ophthalmic and inflammatory diseases is desired.
About BlueRock Therapeutics
BlueRock Therapeutics is a biotechnology company that develops engineered cell therapies to cure diseases. The company's platform is based on induced pluripotent stem cells (iPSCs) and gene editing technologies. BlueRock Therapeutics is focused on developing therapies for diseases of the central nervous system, cardiovascular system, and immunology. The company was founded in 2016 and is headquartered in Cambridge, Massachusetts.